Table 3.
Adverse event overall summary
| Subgroup | PPX SR, n=59 | PPX IR, n=60 |
|---|---|---|
| Patients with any AE | 37 (62.7) | 42 (70.0) |
| Patients with severe AEsa | 6 (10.2) | 5 (8.3) |
| Patients with serious AEsb | 3 (5.1) | 3 (5.0) |
| Patients with drug-related AEs | 25 (42.4) | 33 (55.0) |
| Patients with AEs leading to discontinuation | 5 (8.5) | 1 (1.7) |
Notes:
a
Incapacitating or causing inability to work or undertake usual activities;
b
fatal, life-threatening, requiring hospitalization, or resulting in significant disability. Data are presented as n (%).
Abbreviations: AE, adverse event; IR, immediate release; PPX, pramipexole; SR, sustained release.